Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway.

Mustafa G, Alrohaimi AH, Bhatnagar A, Baboota S, Ali J, Ahuja A.

Drug Deliv. 2016;23(3):933-9. doi: 10.3109/10717544.2014.923064.

PMID:
24959938
2.

Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Johnson NJ, Hanson LR, Frey WH.

Mol Pharm. 2010 Jun 7;7(3):884-93. doi: 10.1021/mp100029t.

3.

Insights into direct nose to brain delivery: current status and future perspective.

Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J.

Drug Deliv. 2014 Mar;21(2):75-86. doi: 10.3109/10717544.2013.838713. Review.

PMID:
24102636
4.

Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation.

Patel MR, Patel RB, Bhatt KK, Patel BG, Gaikwad RV.

Drug Deliv. 2016;23(1):346-54. doi: 10.3109/10717544.2014.914602.

PMID:
24865295
5.

Intranasal drug delivery for brain targeting.

Vyas TK, Shahiwala A, Marathe S, Misra A.

Curr Drug Deliv. 2005 Apr;2(2):165-75. Review.

PMID:
16305417
6.

Drug delivery systems from nose to brain.

Misra A, Kher G.

Curr Pharm Biotechnol. 2012 Sep;13(12):2355-79. Review.

PMID:
23016642
7.
8.

Physicochemical and physiological considerations for efficient nose-to-brain targeting.

Bahadur S, Pathak K.

Expert Opin Drug Deliv. 2012 Jan;9(1):19-31. doi: 10.1517/17425247.2012.636801. Review.

PMID:
22171740
9.
10.

Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.

Mahajan HS, Mahajan MS, Nerkar PP, Agrawal A.

Drug Deliv. 2014 Mar;21(2):148-54. doi: 10.3109/10717544.2013.838014.

PMID:
24128122
11.

Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.

Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J.

Drug Dev Ind Pharm. 2015;41(10):1674-81. doi: 10.3109/03639045.2014.991400.

PMID:
25496439
12.

Nose-to-brain delivery of tacrine.

Jogani VV, Shah PJ, Mishra P, Mishra AK, Misra AR.

J Pharm Pharmacol. 2007 Sep;59(9):1199-205.

PMID:
17883890
13.

Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.

Shinde RL, Bharkad GP, Devarajan PV.

Eur J Pharm Biopharm. 2015 Oct;96:363-79. doi: 10.1016/j.ejpb.2015.08.008.

PMID:
26318978
14.

Recent patents review on intranasal administration for CNS drug delivery.

Jogani V, Jinturkar K, Vyas T, Misra A.

Recent Pat Drug Deliv Formul. 2008;2(1):25-40. Review.

PMID:
19075895
15.

Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.

Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV.

Drug Deliv. 2016;23(1):307-15. doi: 10.3109/10717544.2014.912694.

PMID:
24845478
16.
17.

Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.

Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV.

J Drug Target. 2015;23(9):775-88. doi: 10.3109/1061186X.2015.1020809. Review.

PMID:
25758751
18.

Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.

Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV.

Drug Deliv. 2016;23(1):207-13. doi: 10.3109/10717544.2014.908980.

PMID:
24825492
19.

Optimization of artemether-loaded NLC for intranasal delivery using central composite design.

Jain K, Sood S, Gowthamarajan K.

Drug Deliv. 2015;22(7):940-54. doi: 10.3109/10717544.2014.885999.

PMID:
24512368
20.

Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.

Vyas TK, Babbar AK, Sharma RK, Misra A.

J Drug Target. 2005 Jun;13(5):317-24.

PMID:
16199375
Items per page

Supplemental Content

Support Center